DOCSLIB.ORG

A Two-Step, Two-Signal Model for the Primary Activation of Precursor Helper T Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Two-Step, Two-Signal Model for the Primary Activation of Precursor Helper T Cells Proc. Natl. Acad. Sci. USA Vol. 96, pp. 185–190, January 1999 Immunology A two-step, two-signal model for the primary activation of precursor helper T cells PETER A. BRETSCHER* Department of Microbiology and Immunology, University of Saskatchewan, 107 Wiggins Road, Saskatoon, Saskatchewan, S7N 5E5 Canada Communicated by David W. Talmage, University of Colorado Health Sciences Center, Denver, CO, October 26, 1998 (received for review June 4, 1998) ABSTRACT I present here a new model for the primary cannot account for the observations concerning peripheral tol- activation of precursor helper T cells. Observations demon- erance of Hanahan and coworkers (4). strate that the immune system learns not to respond to The expression of APC costimulatory molecules is, accord- extrathymic, organ-specific self-antigens because of their ing to other contemporary models, induced after the genera- early appearance in development. The immune system thus tion of a third signal. Janeway and coworkers (8, 9) postulated discriminates between peripheral self-antigens and foreign that the immune system does not discriminate self from nonself antigens and, when mature, usually makes an immune re- but rather ‘‘non-infectious self from infectious nonself’’ and sponse against only the latter. Contemporary models for the that microbial products, often present in adjuvants, are re- activation and inactivation of T helper (Th) function do not quired to act on innate defense mechanisms to generate the account for such discrimination. The model proposed here is third signal that initiates an immune response. Matzinger (10) consistent with contemporary findings and incorporates a proposed that the third signal distinguishes danger from mechanism of peripheral self–nonself discrimination. nondanger. According to these models, whether an antigen activates or inactivates available pTh cells is independent of whether the immune system has been previously and contin- A Mechanism of Peripheral Tolerance Exists uously exposed to this antigen from some time early in T cells specific for self-antigens are silenced in the thymus when ontogeny. Rather, only the circumstances at a particular time they encounter an antigen (1). T cells specific for organ-specific are critical at this time. These models cannot account for the antigens emigrate from the thymus and have the potential for observations of Hanahan and coworkers (4). causing organ-specific autoimmunity (2, 3). Hanahan and co- These third-signal models seem implausible on general workers (4) showed that mice that first express a transgenic grounds. Many foreign antigens of nonmicrobiological origin, antigen in pancreatic cells early in ontogeny are tolerant of this such as sterile xenogeneic red blood cells, are immunogenic when ‘‘self’’ antigen, whereas mice that first express the antigen later administered without adjuvant, in contradiction to what Janeway recognize it as ‘‘foreign.’’ The latter mice suffer pancreatic (8) proposed. These red blood cells, self-antigens of species ‘‘autoimmunity’’ after the antigen’s appearance, as expressed by closely related to the animal immunized, are unlikely to activate antibody production and lymphocyte infiltration of the pancreatic innate defense mechanisms of the host (but not of the donor) to islets (4). The immune system thus appears to discriminate self generate the third signal. Human rhesus factor-positive red blood from nonself among peripheral, extrathymic antigens and to rely cells are immunogenic in rhesus factor-negative humans and on the early and continuous presence of peripheral self-antigens must, according to Janeway’s view, generate the third signal. The as their defining characteristic. possibility that some self-antigens generate third signals is unap- pealing, because one would anticipate, within the context of Contemporary Models for the Activation/Inactivation of Janeway’s proposals, that this would lead to organ-specific auto- Precursor Helper T Cells Do Not Account for Peripheral immunity. The idea that injection of all these immunogenic Tolerance antigens results in the generation of a danger signal, as required The activation of naive precursor Th (pTh) cells requires the by the danger model, stretches credulity. generation of two signals (5) according to contemporary models Introduction to the Two-Step, Two-Signal Model (Fig. 1). Signal 1 is generated after the interaction of the T cell receptor (TcR) with its ligand, whereas signal 2 is generated via In this paper I describe a new model for the activation/ an interaction between costimulatory molecules on the antigen- inactivation of naive pTh cells that is consistent with contem- presenting cell (APC) and counterreceptors on the T cell, such as porary facts and incorporates a mechanism of peripheral the well known B7–CD28 interaction. The generation of signal 1 tolerance. alone leads to the inactivation (deletion/anergic state) of the pTh The two-signal model for lymphocyte activation was pro- cell. Contemporary models can be divided into two classes. posed some years ago (11). In the modern context, it incor- According to the Model of Constitutive Costimulation (6, 7), porates a potential mechanism of peripheral self-tolerance. Observations support the validity of this model for most B cells APCs, such as mature dendritic cells, constitutively express 1 costimulatory molecules. Constitutive costimulation cannot be (12) and for at least some CD8 T cells (13, 14). However, the centrally involved in the decision between the activation/ model, as it pertains to the activation/inactivation of pTh cells, inactivation of pTh cells, if these processes are to be related to cannot be reconciled with contemporary facts. A discussion of peripheral tolerance. Such a mechanism cannot favor the acti- this model provides a convenient context for considering vation of pTh cells specific for foreign peptides and the inacti- contemporary findings and the basis of the new model. The original two-signal model postulated that the activation vation of those pTh cells specific for self-peptides. This model of a resting lymphocyte requires the antigen-mediated inter- The publication costs of this article were defrayed in part by page charge Abbreviations: Th, T helper; pTh, precursor T helper; TcR, T cell payment. This article must therefore be hereby marked ‘‘advertisement’’ in receptor; APC, antigen-presenting cell; eTh, effector T helper; MHC, accordance with 18 U.S.C. §1734 solely to indicate this fact. major histocompatibility complex. © 1999 by The National Academy of Sciences 0027-8424y99y96185-6$2.00y0 *To whom reprint requests should be addressed. e-mail: bretschr@ PNAS is available online at www.pnas.org. duke.usask.ca. 185 Downloaded by guest on September 26, 2021 186 Immunology: Bretscher Proc. Natl. Acad. Sci. USA 96 (1999) signal model (Fig. 2). Effective help by carrier-specific T cells for the activation of hapten-specific B cells was observed only when the challenge was with the hapten–carrier conjugate and not when hapten and carrier were both present but unconju- gated. This ‘‘recognition of linked epitopes’’ is central in ensuring the specificity of the activity of helper T cells. Thus, Th cells specific for an antigen Q can help only the antibody response to Q and not a response to a non-crossreacting antigen L in the presence of both Q and L. This antigen bridge model appears inconsistent with the fact that ab Th cells recognize a peptide, derived from a nominal antigen, bound by a major histocompatibility complex (MHC) restriction element. How can there be a requirement for hapten– carrier linkage if the hapten–carrier conjugate must be degraded into peptides, unlinked to the hapten, before the carrier-specific ab T cells can recognize the ‘‘nominal’’ carrier? Lanzavecchia (16) resolved this paradox. He showed that hapten-specific B cells FIG. 1. Contemporary models for the activation of pTh cells. For endocytose the hapten–carrier conjugate, process it to yield a detailed explanation, see the text. The generation of signal 1 alone carrier-derived peptides that then bind to nascently synthesized results in inactivation, whereas activation requires the generation of class II MHC molecules. Peptide-loaded class II MHC molecules, both signal 1 and signal 2 (costimulatory signal). subsequently expressed on the B cell surface, can be recognized by carrier-specific Th cells. This mechanism explains why carrier- action of this lymphocyte with another ‘‘helper ’’ lymphocyte specific Th cells can help hapten-specific B cells only if the hapten specific for this antigen, whereas its inactivation occurs when is attached to that carrier. this single lymphocyte interacts with antigen alone. These rules An even more acute problem arises if it is believed that the incorporate a process of peripheral tolerance. Lymphocytes activation of pTh cells requires a pTh cell–eTh cell interaction specific for a self-antigen are eliminated as they are generated mediated by the recognition of linked epitopes, as postulated one (or a few) at a time, by virtue of the continuous presence by the original two-signal model. of the antigen. In contrast, lymphocytes, specific for a foreign (ii) Constitutive Costimulation. The Model of Constitutive but not for any self-antigen, can accumulate in the absence of Costimulation bears a superficial resemblance to the original the foreign antigen. Once this foreign antigen impinges on the two-signal model. The crucial difference is that the costimulatory immune system, it can
Load more

Recommended publications
  • B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells
    cells Review B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells Carlo G. Bonasia 1 , Wayel H. Abdulahad 1,2 , Abraham Rutgers 1, Peter Heeringa 2 and Nicolaas A. Bos 1,* 1 Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] (C.G.B.); [email protected] (W.H.A.); [email protected] (A.R.) 2 Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] * Correspondence: [email protected] Abstract: Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the production of autoantibodies, secretion of cytokines, and presentation of autoantigens to T cells. However, the mechanisms that underlie the development of autoreactive B cells are not well understood. Here, we review recent studies leveraging novel techniques to identify and characterize (auto)antigen-specific B cells. The insights gained from such studies pertaining to the mechanisms involved in the escape of tolerance checkpoints and the activation of autoreactive B cells are discussed. Citation: Bonasia, C.G.; Abdulahad, W.H.; Rutgers, A.; Heeringa, P.; Bos, In addition, we briefly highlight potential therapeutic strategies to target and eliminate autoreactive N.A. B Cell Activation and Escape of B cells in autoimmune diseases. Tolerance Checkpoints: Recent Insights from Studying Autoreactive Keywords: autoimmune diseases; B cells; autoreactive B cells; tolerance B Cells. Cells 2021, 10, 1190. https:// doi.org/10.3390/cells10051190 Academic Editor: Juan Pablo de 1.
    [Show full text]
  • Of T Cell Tolerance
    cells Review Strength and Numbers: The Role of Affinity and Avidity in the ‘Quality’ of T Cell Tolerance Sébastien This 1,2,† , Stefanie F. Valbon 1,2,†, Marie-Ève Lebel 1 and Heather J. Melichar 1,3,* 1 Centre de Recherche de l’Hôpital Maisonneuve-Rosemont, Montréal, QC H1T 2M4, Canada; [email protected] (S.T.); [email protected] (S.F.V.); [email protected] (M.-È.L.) 2 Département de Microbiologie, Immunologie et Infectiologie, Université de Montréal, Montréal, QC H3C 3J7, Canada 3 Département de Médecine, Université de Montréal, Montréal, QC H3T 1J4, Canada * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: The ability of T cells to identify foreign antigens and mount an efficient immune response while limiting activation upon recognition of self and self-associated peptides is critical. Multiple tolerance mechanisms work in concert to prevent the generation and activation of self-reactive T cells. T cell tolerance is tightly regulated, as defects in these processes can lead to devastating disease; a wide variety of autoimmune diseases and, more recently, adverse immune-related events associated with checkpoint blockade immunotherapy have been linked to a breakdown in T cell tolerance. The quantity and quality of antigen receptor signaling depend on a variety of parameters that include T cell receptor affinity and avidity for peptide. Autoreactive T cell fate choices (e.g., deletion, anergy, regulatory T cell development) are highly dependent on the strength of T cell receptor interactions with self-peptide. However, less is known about how differences in the strength Citation: This, S.; Valbon, S.F.; Lebel, of T cell receptor signaling during differentiation influences the ‘function’ and persistence of anergic M.-È.; Melichar, H.J.
    [Show full text]
  • B Lymphocytes in Neuromyelitis Optica
    VIEWS & REVIEWS B lymphocytes in neuromyelitis optica Jeffrey L. Bennett, MD, ABSTRACT PhD Neuromyelitis optica (NMO) is an inflammatory autoimmune disorder of the CNS that predomi- ’ Kevin C. O Connor, PhD nantly affects the spinal cord and optic nerves. A majority (approximately 75%) of patients with Amit Bar-Or, MD, FRCP NMO are seropositive for autoantibodies against the astrocyte water channel aquaporin-4 Scott S. Zamvil, MD, (AQP4). These autoantibodies are predominantly IgG1, and considerable evidence supports their PhD pathogenicity, presumably by binding to AQP4 on CNS astrocytes, resulting in astrocyte injury Bernhard Hemmer, MD and inflammation. Convergent clinical and laboratory-based investigations have indicated that Thomas F. Tedder, PhD B cells play a fundamental role in NMO immunopathology. Multiple mechanisms have been H.-Christian von hypothesized: AQP4 autoantibody production, enhanced proinflammatory B cell and plasmablast Büdingen, MD activity, aberrant B cell tolerance checkpoints, diminished B cell regulatory function, and loss of Olaf Stuve, MD, PhD B cell anergy. Accordingly, many current off-label therapies for NMO deplete B cells or modulate Michael R. Yeaman, PhD their activity. Understanding the role and mechanisms whereby B cells contribute to initiation, Terry J. Smith, MD maintenance, and propagation of disease activity is important to advancing our understanding Christine Stadelmann, of NMO pathogenesis and developing effective disease-specific therapies. Neurol Neuroimmunol MD Neuroinflamm 2015;2:e104;
    [Show full text]
  • Coordination of T Cell Activation and Migration Through Formation of the Immunological Synapse
    Coordination of T Cell Activation and Migration through Formation of the Immunological Synapse MICHAEL L. DUSTIN Program in Molecular Pathogenesis, Skirball Institute of Biomolecular Medicine and the Department of Pathology, New York University School of Medicine, New York, New York 10016, USA ABSTRACT: T cell activation is based on interactions of T cell antigen receptors with MHC-peptide complexes in a specialized cell–cell junction between the T cell and antigen-presenting cell—the immunological synapse. The immunolog- ical synapse coordinates naïve T cell activation and migration by stopping T cell migration with antigen-presenting cells bearing appropriate major histo- compatibility complex (MHC) peptide complexes. At the same time, the immu- nological synapse allows full T cell activation through sustained signaling over a period of several hours. The immunological synapse supports activation in the absence of continued T cell migration, which is required for T cell activa- tion through serial encounters. Src and Syk family kinases are activated early in immunological synapse formation, but this signaling process returns to the basal level after 30 min; at the same time, the interactions between T cell re- ceptors (TCRs) and MHC peptides are stabilized within the immunological synapse. The molecular pattern of the mature synapse in helper T cells is a self- stabilized structure that is correlated with cytokine production and prolifera- tion. I propose that this molecular pattern and its specific biochemical constit- uents are necessary
    [Show full text]
  • The Importance of Dendritic Cells in Maintaining Immune Tolerance Cindy Audiger, M
    The Importance of Dendritic Cells in Maintaining Immune Tolerance Cindy Audiger, M. Jubayer Rahman, Tae Jin Yun, Kristin V. Tarbell and Sylvie Lesage This information is current as of October 1, 2021. J Immunol 2017; 198:2223-2231; ; doi: 10.4049/jimmunol.1601629 http://www.jimmunol.org/content/198/6/2223 Downloaded from References This article cites 166 articles, 73 of which you can access for free at: http://www.jimmunol.org/content/198/6/2223.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 1, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Th eJournal of Brief Reviews Immunology The Importance of Dendritic Cells in Maintaining Immune Tolerance x { Cindy Audiger,*,†,1 M. Jubayer Rahman,‡,1 Tae Jin Yun, , Kristin V. Tarbell,‡ and Sylvie Lesage*,† Immune tolerance is necessary to prevent the immune specific depletion of CD11c+ cells (3).
    [Show full text]
  • The New Aspects of Aminoacyl-Trna Synthetases
    Vol. 47 No. 3/2000 821–834 QUARTERLY Review The new aspects of aminoacyl-tRNA synthetases. Maciej Szymañski, Marzanna Deniziak and Jan Barciszewski½ Institute of Bioorganic Chemistry of the Polish Academy of Sciences, 60-704 Poznañ, Poland Received: 29 December, 1999; revised: 24 May, 2000; accepted: 02 June, 2000 Key words: aminoacylation, aminoacyl-tRNA synthetases, protein biosynthesis, tRNA Aminoacyl-tRNA synthetases (AARS) are essential proteins found in all living organ- isms. They form a diverse group of enzymes that ensure the fidelity of transfer of ge- netic information from the DNA into the protein. AARS catalyse the attachment of amino acids to transfer RNAs and thereby establish the rules of the genetic code by virtue of matching the nucleotide triplet of the anticodon with its cognate amino acid. Here we summarise the effects of recent studies on this interesting family of multifunctional enzymes. The universal genetic code is established in a only components of the gene expression appa- single aminoacylation reaction of transfer ri- ratus that function at the interface between bonucleic acids (tRNAs). The reaction is nucleic acids and proteins. This leads to three catalysed by the family of aminoacyl-tRNA interesting aspects of studies on amino- synthetases (AARS) each of which activates acyl-tRNA synthetases: (i) the mechanism of an amino acid by binding to ATP and trans- amino acid recognition and chemical activa- fers it to the 3¢ end of the cognate tRNA. The tion, (ii) the specificity of tRNA recognition, conservation of the genetic code suggests that and (iii) the origin and evolution of AARS [3].
    [Show full text]
  • Lymphocyte-Activation Gene 3 (LAG-3) Immune Pathway
    Lymphocyte-Activation Gene 3 (LAG-3) About LAG-3 LAG-3 Lymphocyte-activation gene 3 (LAG-3) is an immune checkpoint receptor protein found on the cell surface of effector T cells and regulatory T cells (Tregs) and functions to control T cell response, activation and growth.1 TCR T cells are a type of white blood cell that are part of the immune system. Activation of cytotoxic T cells by antigens enables them to 1 kill unhealthy or foreign cells. Inactive T cell Antigen MHC Dendritic cell (APC) LAG-3 and LAG-3 and LAG-3 and Immune Function T Cell Exhaustion Cancer • After a T cell is activated to kill its • However, in certain situations where T • Because of its critical role in regulating target cell, LAG-3 expression is cells experience prolonged exposure to an exhaustion of cytotoxic T cells and Treg increased to turn off the immune antigen, such as cancer or chronic function, LAG-3 has become a target of response, so that the T cell does not go infection, the T cells become desensitized study in the cancer field. on to attack healthy cells.2 and lose their ability to activate and multiply in the presence of the antigen.4 • In cancer, LAG-3 expressing exhausted • Inhibition of the immune response is cytotoxic T cells and Tregs expressing accomplished through activation of • The desensitized T cell will also LAG-3 gather at tumor sites.5,6 the LAG-3 pathway, which can occur progressively fail to produce cytokines via binding of LAG-3 to a type of (proteins that assist in the immune • Preclinical studies suggest that inhibiting antigen-presenting complex called response) and kill the target cells.4 LAG-3 allows T cells to regain their MHC II.
    [Show full text]
  • Induction of Peripheral Tolerance in Ongoing Autoimmune Inflammation Equirr Es Interleukin 27 Signaling in Dendritic Cells
    Thomas Jefferson University Jefferson Digital Commons Department of Neurology Faculty Papers Department of Neurology 10-27-2017 Induction of peripheral tolerance in ongoing autoimmune inflammation equirr es interleukin 27 signaling in dendritic cells Rodolfo Thome Thomas Jefferson University Jason N. Moore Thomas Jefferson University Elisabeth R. Mari Thomas Jefferson University Javad Rasouli Thomas Jefferson University Follow this and additional works at: https://jdc.jefferson.edu/neurologyfp Part of the Medical Immunology Commons, and the Neurology Commons Let us know how access to this document benefits ouy Recommended Citation Thome, Rodolfo; Moore, Jason N.; Mari, Elisabeth R.; and Rasouli, Javad, "Induction of peripheral tolerance in ongoing autoimmune inflammation equirr es interleukin 27 signaling in dendritic cells" (2017). Department of Neurology Faculty Papers. Paper 139. https://jdc.jefferson.edu/neurologyfp/139 This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Department of Neurology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please contact: [email protected]. ORIGINAL RESEARCH published: 27 October 2017 doi: 10.3389/fimmu.2017.01392 Induction of Peripheral Tolerance in Ongoing autoimmune inflammation Requires Interleukin 27 Signaling in Dendritic Cells Rodolfo Thomé1, Jason N.
    [Show full text]
  • Immune Regulation and Tolerance
    Mechanisms of unresponsiveness: Immunological Ignorance Immune Regulation Normal response and Proliferation and Tolerance differentiation Mechanisms of Antigen/lymphocyte barrier unresponsiveness Mechanisms of Tissue abnormalities contributing to release and Yong-Rui Zou (Oct. 2005) autoimmunity presentation of self antigens. [email protected] Disease models Sympathetic ophthalmia, experimental allergic encephalomyelitis (EAE) Immunoregulation: A balance between activation and Mechanisms of unresponsiveness: suppression of effector cells to achieve an efficient Central tolerance in B and T cells (I): Clonal Deletion immune response without damaging the host. Self antigen presented in generative Activation (immunity) Suppression (tolerance) lymphoid Deletion of immature organs lymphocytes strongly recognizing self antigens autoimmunity immunodeficiency present in generative organs Lymphoid precursor Significance: The induction of tolerance may be Survival of clones which are only moderately exploited to prevent graft rejection, to treat autoimmune responsive to self antigens and allergic diseases, and to prevent immune responses present in generative in gene therapy. organs; forms T/B cell repertoire Important features of immunoregulation: 1. Antigen specific; affects T or B lymphocytes Science 298:1395 (2002) 2. Tolerance vs. activation? Determined by the nature of antigen and associated stimuli, and when and where the antigen is encountered Immunity 23:227 (2005) 1 Mechanisms of unresponsiveness: AIRE: Autoimmune regulator. Peripheral tolerance in B cells (I): Anergy Immunogenic signaling Tolerogenic signaling • Transcription factor. • Expressed at a high level by thymic medullar epithelium Acute Chronic cells. antigens antigens CD40L • Autosomal recessive mutation leads to autoimmune LPS polyendocrine syndrom - type 1 (APS-1). CD40 CD40 TLR4 • Inactivation of aire abolishes expression of some tissue TLR4 BCR BCR Fcγ2b specific genes in the thymic medulla.
    [Show full text]
  • An in Vitro Approach to Detect Metabolite Toxicity Due to CYP3A4
    Toxicology 216 (2005) 154–167 An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics Luisella Vignati ∗, Elisa Turlizzi 1, Sonia Monaci, Pietro Grossi, Ruben de Kanter, Mario Monshouwer 2 Department of Pre-Clinical Development, Nerviano Medical Sciences S.r.l., V.le Pasteur, 10, 20014, Nerviano, MI, Italy Received 22 June 2005; received in revised form 3 August 2005; accepted 3 August 2005 Available online 19 September 2005 Abstract Many adverse drug reactions are caused by the cytochrome P450 (CYP) dependent activation of drugs into reactive metabolites. In order to reduce attrition due to metabolism-mediated toxicity and to improve safety of drug candidates, we developed two in vitro cell-based assays by combining an activating system (human CYP3A4) with target cells (HepG2 cells): in the first method we incubated microsomes containing cDNA-expressed CYP3A4 together with HepG2 cells; in the second approach HepG2 cells were transiently transfected with CYP3A4. In both assay systems, CYP3A4 catalyzed metabolism was found to be comparable to the high levels reported in hepatocytes. Both assay systems were used to study ten CYP3A4 substrates known for their potential to form metabolites that exhibit higher toxicity than the parent compounds. Several endpoints of toxicity were evaluated, and the measurement of MTT reduction and intracellular ATP levels were selected to assess cell viability. Results demonstrated that both assay systems are capable to metabolize the test compounds leading to increased toxicity, compared to their respective control systems. The co-incubation with the CYP3A4 inhibitor ketoconazole confirmed that the formation of reactive metabolites was CYP3A4 dependent.
    [Show full text]
  • Type 1 Regulatory T Cells: a New Mechanism of Peripheral Immune Tolerance
    Cellular & Molecular Immunology (2015) 12, 566–571 ß 2015 CSI and USTC. All rights reserved 1672-7681/15 $32.00 www.nature.com/cmi REVIEW Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance Hanyu Zeng, Rong Zhang, Boquan Jin and Lihua Chen The lack of immune response to an antigen, a process known as immune tolerance, is essential for the preservation of immune homeostasis. To date, two mechanisms that drive immune tolerance have been described extensively: central tolerance and peripheral tolerance. Under the new nomenclature, thymus-derived regulatory T (tTreg) cells are the major mediators of central immune tolerance, whereas peripherally derived regulatory T (pTreg) cells function to regulate 1 peripheral immune tolerance. A third type of Treg cells, termed iTreg, represents only the in vitro-induced Treg cells . Depending on whether the cells stably express Foxp3, pTreg, and iTreg cells may be divided into two subsets: the classical 1 1 1 2 2 CD4 Foxp3 Treg cells and the CD4 Foxp3 type 1 regulatory T (Tr1) cells . This review focuses on the discovery, associated biomarkers, regulatory functions, methods of induction, association with disease, and clinical trials of Tr1 cells. Cellular & Molecular Immunology (2015) 12, 566–571; doi:10.1038/cmi.2015.44; published online 8 June 2015 Keywords: biomarkers; clinical trials; regulatory functions; type 1 regulatory T cells INTRODUCTION functions of these cells and ultimately to apply this knowledge The induction and formation of peripheral immune tolerance to the treatment of associated diseases. is essential to maintaining stability of the immune system. In addition to the immune system’s major roles in regulating THE DISCOVERY OF TR1 CELLS clonal deletion, antigen sequestration, and expression at privi- Tr1 cells were first described by Roncarolo et al.
    [Show full text]
  • The Anatomy of T-Cell Activation and Tolerance Anna Mondino*T, Alexander Khoruts*, and Marc K
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 2245-2252, March 1996 Review The anatomy of T-cell activation and tolerance Anna Mondino*t, Alexander Khoruts*, and Marc K. Jenkins Department of Microbiology and the Center for Immunology, University of Minnesota Medical School, 420 Delaware Street S.E, Minneapolis, MN 55455 ABSTRACT The mammalian im- In recent years, it has become clear that TCR is specific for a self peptide-class I mune system must specifically recognize a full understanding of immune tolerance MHC complex) T cell that will exit the and eliminate foreign invaders but refrain cannot be achieved with reductionist in thymus and seed the secondary lymphoid from damaging the host. This task is vitro approaches that separate the individ- tissues (3, 4). In contrast, cortical CD4+ accomplished in part by the production of ual lymphocyte from its in vivo environ- CD8+ thymocytes that express TCRs that a large number of T lymphocytes, each ment. The in vivo immune response is a have no avidity for self peptide-MHC bearing a different antigen receptor to well-organized process that involves mul- complexes do not survive and die by an match the enormous variety of antigens tiple interactions of lymphocytes with each apoptotic mechanism. Cortical epithelial present in the microbial world. However, other, with bone-marrow-derived antigen- cells are essential for the process of pos- because antigen receptor diversity is gen- presenting cells (APCs), as well as with itive selection because they display the self erated by a random mechanism, the im- nonlymphoid cells and their products. The peptide-MHC complexes that are recog- mune system must tolerate the function of anatomic features that are designed to op- nized by CD4+ CD8+ thymocytes and also T lymphocytes that by chance express a timize immune tolerance toward innocuous provide essential differentiation factors self-reactive antigen receptor.
    [Show full text]